Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean W Felsher

Showing results (91-100 of 146) with videos related to

Pageof 15
Sort By:
ACS Medicinal Chemistry Letters|April 22, 2022
Azapodophyllotoxin Causes Lymphoma and Kidney Cancer Regression by Disrupting Tubulin and MonoglycerolsArvin M Gouw, Vineet Kumar, Angel Resendez, et al.
Cancer Research Communications|November 16, 2022
Na<sup>+</sup>/H<sup>+</sup>-exchanger 1 enhances antitumor activity of engineered NK-92 natural killer cellsYao-Yu Gong, Hongguang Shao, Yu Li, et al.
Journal of Hepatology|June 26, 2013
Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinomaTamar Kapanadze, Jaba Gamrekelashvili, Chi Ma, et al.
Lab on a Chip|May 9, 2012
High throughput automated chromatin immunoprecipitation as a platform for drug screening and antibody validationAngela R Wu, Tiara L A Kawahara, Nicole A Rapicavoli, et al.
Oncogene|October 7, 2022
MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changesDelaney K Sullivan, Anja Deutzmann, Josiah Yarbrough, et al.
Hepatology (Baltimore, Md.)|December 24, 2008
Autochthonous liver tumors induce systemic T cell tolerance associated with T cell receptor down-modulationJasmin T Ney, Thomas Schmidt, Christian Kurts, et al.
Molecular Therapy. Nucleic Acids|August 18, 2020
MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCCRenumathy Dhanasekaran, Jangho Park, Alekesey Yevtodiyenko, et al.
Nature Communications|February 1, 2024
Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinomaAnja Deutzmann, Delaney K Sullivan, Renumathy Dhanasekaran, et al.
Plos Biology|September 30, 2004
Developmental context determines latency of MYC-induced tumorigenesisShelly Beer, Anders Zetterberg, Rebecca A Ihrie, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2010
Development of a micro-computed tomography-based image-guided conformal radiotherapy system for small animalsHu Zhou, Manuel Rodriguez, Fred van den Haak, et al.
Pageof 15

Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
ACS Medicinal Chemistry Letters|April 22, 2022
Azapodophyllotoxin Causes Lymphoma and Kidney Cancer Regression by Disrupting Tubulin and MonoglycerolsArvin M Gouw, Vineet Kumar, Angel Resendez, et al.
Cancer Research Communications|November 16, 2022
Na<sup>+</sup>/H<sup>+</sup>-exchanger 1 enhances antitumor activity of engineered NK-92 natural killer cellsYao-Yu Gong, Hongguang Shao, Yu Li, et al.
Journal of Hepatology|June 26, 2013
Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinomaTamar Kapanadze, Jaba Gamrekelashvili, Chi Ma, et al.
Lab on a Chip|May 9, 2012
High throughput automated chromatin immunoprecipitation as a platform for drug screening and antibody validationAngela R Wu, Tiara L A Kawahara, Nicole A Rapicavoli, et al.
Oncogene|October 7, 2022
MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changesDelaney K Sullivan, Anja Deutzmann, Josiah Yarbrough, et al.
Hepatology (Baltimore, Md.)|December 24, 2008
Autochthonous liver tumors induce systemic T cell tolerance associated with T cell receptor down-modulationJasmin T Ney, Thomas Schmidt, Christian Kurts, et al.
Molecular Therapy. Nucleic Acids|August 18, 2020
MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCCRenumathy Dhanasekaran, Jangho Park, Alekesey Yevtodiyenko, et al.
Nature Communications|February 1, 2024
Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinomaAnja Deutzmann, Delaney K Sullivan, Renumathy Dhanasekaran, et al.
Plos Biology|September 30, 2004
Developmental context determines latency of MYC-induced tumorigenesisShelly Beer, Anders Zetterberg, Rebecca A Ihrie, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2010
Development of a micro-computed tomography-based image-guided conformal radiotherapy system for small animalsHu Zhou, Manuel Rodriguez, Fred van den Haak, et al.
Pageof 15